Haemonetics (HAE) Amortization of Deferred Charges (2012 - 2024)
Haemonetics (HAE) posted Amortization of Deferred Charges of $782000.0 for Q1 2024, little changed on a QoQ basis from $783000.0 in Q4 2023, and down 10.32% year-over-year from $872000.0 in Q1 2023.
Powered by 
Analysis
Haemonetics (HAE) Amortization of Deferred Charges (2012 - 2024) Analysis & Trends
Haemonetics has reported Amortization of Deferred Charges for 9 years, with the latest figure at $782000.0 in Q1 2024.
- On a quarterly basis, Amortization of Deferred Charges fell 10.32% year-over-year to $782000.0 in Q1 2024; TTM through Mar 2024 was $3.2 million, a 61.17% increase from a year earlier, with the FY2024 full-year figure at $3.2 million, up 61.17% from the prior year.
- Amortization of Deferred Charges was $782000.0 for Q1 2024 at Haemonetics, roughly flat from $783000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $1.0 million in Q3 2021, with the low at -$484000.0 in Q4 2022.
- Average Amortization of Deferred Charges over 5 years is $630500.0, with a median of $789500.0 recorded in 2021.
- The largest YoY upside for Amortization of Deferred Charges was 472.66% in 2022 against a maximum downside of 160.96% in 2022.
- Over 5 years, Amortization of Deferred Charges stood at $139000.0 in 2020, then soared by 471.22% to $794000.0 in 2021, then fell by 1.13% to $785000.0 in 2022, then fell by 0.25% to $783000.0 in 2023, then retreated by 0.13% to $782000.0 in 2024.
- The last three Amortization of Deferred Charges figures came in at $782000.0 (Q1 2024), $783000.0 (Q4 2023), and $780000.0 (Q3 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Haemonetics | 4.60 Bn | 4.37 Bn | 202.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 30, 2024 | 782,000.00 |
| Dec 30, 2023 | 783,000.00 |
| Sep 30, 2023 | 780,000.00 |
| Jul 1, 2023 | 830,000.00 |
| Apr 1, 2023 | 872,000.00 |
| Dec 31, 2022 | 785,000.00 |
| Oct 1, 2022 | -484,000.00 |
| Jul 2, 2022 | 797,000.00 |
| Apr 2, 2022 | 796,000.00 |
| Jan 1, 2022 | 795,000.00 |
| Oct 2, 2021 | 794,000.00 |
| Jul 3, 2021 | 1.02 Mn |
| Apr 3, 2021 | 139,000.00 |
| Dec 26, 2020 | 139,000.00 |
| Dec 26, 2015 | 213,000.00 |
| Sep 26, 2015 | 213,000.00 |
| Jun 27, 2015 | 222,000.00 |
| Mar 28, 2015 | 216,000.00 |
| Dec 27, 2014 | 225,000.00 |
| Sep 27, 2014 | 225,000.00 |